Silence Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
AstraZeneca USD 388M 0 2024-12
Autolus Therapeutics Ltd 130K 0 2024-09
Hikma Pharmaceutical USD 40M 0 2024-06
Novartis USD 793M 0 2024-12
Roche Holding CHF 107M 0 2024-06
Silence Therapeutics 7.08M 63K 2024-09



Silence Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.